Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-06-01
著者
-
OHNO Ryuzo
Aichi Cancer Center
-
MATSUDA Shin
Center for Hematopoietic Disorders, Ohta Nishinouchi Hospital, The Ohta Foundation
-
ASOU Norio
Department of Hematology, Kumamoto University School of Medicine
-
KATO Shunichi
Department of Cell Transplantation and Regenerative Medicine, Tokai University School of Medicine
-
MORISHIMA Yasuo
Department of Hematology and Cell Therapy, Aichi Cancer Center
-
NAKAMURA Shigeo
Department of Clinical Pathology, Aichi Cancer Center Hospital
-
TOMONAGA Masao
Department of Hematology, Atomic Disease Institute, Nagasaki University School of Medicine
-
KODERA Yoshihisa
Department of Hematology, Japanese Red Cross Nagoya First Hospital
-
SHIMOYAMA Masanori
National Cancer Center Hospital
-
KOJIMA Masaru
Department of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine
-
Nakamura Shigeo
群馬県立がんセンター 病理検査
-
Kishimoto Yuji
The First Department Of Internal Medicine Kansai Medical University
-
Maeda S
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Miura S
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Seto M
Department Of Hematology And Chemotherapy
-
Seto Masao
東京大学医学部附属病院 無菌治療部
-
HAMAJIMA Nobuyuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
-
Kojima M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
KAMI Masahiro
Department of Hematology, Toranomon Hospital
-
HIRAI Hisamaru
Department of Hematology and Oncology, Graduate School of Medicine
-
Kagami Y
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Kagami Yoshitoyo
名古屋大学医学部附属病院 病理部
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Miyawaki Shuichi
Leukemia Research Center Saiseikai Maebashi Hospital
-
Ohtake S
Department Of Hematology Kanazawa University Graduate School Of Medical Science
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
OHTAKE Shigeki
Third Department of Internal Medicine, Kanazawa University School of Medicine
-
SETO Masao
Division of Molecular Medicine, Aichi Cancer Center Research Institute
-
ASOU Norio
Second Department of Internal Medicine, Kumamoto University School of Medicine
-
Shimoyama M
Department Of Hematology Anjo Kosei Hospital
-
Sawa Masashi
Department Of Molecular Medicine And Hematology Nagoya University Graduate School Of Medicine
-
Kanakura Yuzuru
大阪大学 医学系研究科心臓血管外科
-
Asou Norio
愛知県がんセンター
-
Asou N
Department Of Hematology Kumamoto University School Of Medicine
-
Asou Norio
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Asou Norio
Department Of Hematology And Infectious Diseases Kumamoto University Graduate School Of Medical Scie
-
Takeuchi Jin
Department Of Hematology And Rheumatology Nihon University School Of Medicine
-
Suzuki R
Department Of Hsct Data Management Nagoya University Hospital
-
Suzuki Ritsurou
東京大学医学部附属病院 無菌治療部
-
Suzuki Ritsuro
豊橋市民病院 血液･腫瘍内科
-
Suzuki Ritsuro
Division Of Molecular Medicine Aichi Cancer Center
-
Hamajima N
Department Of Preventive Medicine-biostatistics And Medical Decision Making Nagoya University Gradua
-
Hamajima Nobuyuki
愛知県がんセンター研究所 疫学･予防部
-
Hamajima Nobuyuki
Department Of Preventive Medicine/biostatistics And Medical Decision Making Nagoya University Gradua
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Hirai Hisamaru
Department Of Hematology And Oncology Graduate School Of Medicine
-
Tanaka J
Stem Cell Transplantation Center Hokkaido University Hospital
-
Kato Shunichi
Cell Transplantation And Regenerative Medicine Tokai University School Of Medicine
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Kume M
Department Of Hematology Sapporo Hokuyu Hospital
-
SANO Masayuki
Departments of Internal Medicine Saga Medical School
-
Sakai Mari
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Nakamura S
Department Of Pathology And Clinical Laboratories Nagoya University Hospital
-
Nakamura Shigeo
Department Of Pathology Nagoya University School Of Medicine
-
TAKEUCHI Jin
First Department of Internal Medicine, Nihon University School of Medicine
-
Kasai M
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
MURATA Makoto
Nagoya University School of Medicine
-
MASAKI Yasufumi
Department of Internal Medicine, Kanazawa Medical University
-
KUSUMOTO Shuya
First Department of Internal Medicine, Saitama Medical School
-
YORIMITSU Seiichi
Department of Internal Medicine, Kochi Central Hospital
-
Kikuchi Masahiro
福岡大学 医学部内科学第一
-
Sato M
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
Sano Masayuki
Niigata Cancer Center Hospital
-
Kato M
Department Of Internal Medicine & Molecular Science Nagoya City University Graduate School Of Me
-
Kusumoto Shuya
First Department Of Internal Medicine Saitama Medical School
-
Asou Norio
Department Of Hematology Kumamoto University School Of Medicine
-
Kato Shunichi
Department Of Cell Transplantation And Regenerative Medicine Tokai University School Of Medicine
-
Nakamura Shigeo
Department Of Pathology Nagoya University Graduate School Of Medicine
-
Hamajima Nobuyuki
Department Of Preventive Medicine Aichi Cancer Center Research Institute
-
Kume Masaaki
Division Of Hematology And Oncology Department Of Medicine Akita University School Of Medicine
-
Shamoto M
Fujita Health Univ. Toyoake Jpn
-
Kojima Masaru
Department Of Anatomic And Diagnostic Pathology Dokkyo University School Of Medicine
-
Minami S
Nagasaki Cml Study Group
-
Matsuda Shin
Center For Hematopoietic Disorders Ohta Nishinouchi Hospital The Ohta Foundation
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Yorimitsu Seiichi
Department Of Internal Medicine Kochi Central Hospital
-
Suzuki Ritsurou
Department Of Hematology And Chemotherapy Aichi Cancer Center
-
Kato Shunichi
Department Of Cell Transplantation And Regenerative Medicine Tokai University
-
Miura Shigeto
Department Of Breast Surgery Aichi Cancer Center Hospital
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Miyawaki Shuichi
Saiseikai Maebashi Hospital Maebashi Jpn
-
Hirai Hisamaru
Department Of Hematology And Oncology Faculty Of Medicine University Of Tokyo
-
Hirai Hisamaru
Department Of Cell Therapy And Transplantation University Of Tokyo
-
Kami Masahiro
Division Of Hematology/oncology Kameda General Hospital
-
Hamajima Nobuyuki
Division Of Epidemiology Aichi Cancer Center Research Institute
-
Kasai Masanobu
First Department Of Internal Medicine Nagoya University School Of Medicine
-
Murata M
Japan Marrow Donor Program Marrow Transplant Promotion Foundation Data And Sample Management Committ
-
Kodera Yoshihisa
Department Of Hematology Japanese Red Cross Nagoya First Hospital
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Seto Masao
Division Of Molecular Medicine Aichi Cancer Center
-
Kagami Yoshitoyo
Department Of Pathology School Of Medicine Kurume University
-
Matsuyama Toshifumi
Department Of Molecular Microbiology And Immunology Nagasaki University Graduate School Of Medicine
-
Tomonaga Masao
Department Of Haematology Atomic Bomb Disease Institute Nafasaki University School Of Medicine
-
Takeuchi Jin
Department Of Internal Medicine Nihon University School Of Medicine
-
Takeuchi Jin
First Department Of Internal Medicine Nihon University School Of Medicine
-
Kami Masahiro
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center
-
Taguchi Jun
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taguchi Jun
Department Of Hematology Kanagawa Cancer Center
-
Kojima Masaru
Department Of Anatomic And Diagnostic Pathology Dokkyo Medical University
-
Suzuki Ritsuro
Department Of Hsct Data Management And Biostatistics Nagoya University School Of Medicine
-
Murata Makoto
Department Of Hematology Nagoya University Graduate School Of Medicine
-
Yano Kunio
県西部浜松医療センター
-
Hirabayashi Noriyuki
Department Of Hematology Nagoya Daini Red Cross Hospital
-
Moritaka S
Department Of Surgery Ii Nagoya City University Medical School
-
Masaki Yasufumi
Department Of Hematology Kinki University School Of Medicine
-
Kobayashi Masahide
The Department Of Hematology Hamamatsu West Medical Center
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Asano Naoko
Department Of Laboratory Medicine Shinshu University Hospital
-
Asano Naoko
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Masaki Yasufumi
Department Of Hematology And Immunology Kanazawa Medical University
-
Nakamura Shigeo
Department Of Cardiovascular Diseases. Kokura National Hospital
-
Suzuki Risturo
Division Of Molecular Medicine Aichi Cancer Center Research Institute
-
NAKAMURA Shigeo
Department of Applied Chemistry, Faculty of Engineering, Kanagawa University
-
KODERA Yoshihisa
Department of Hematology and Rheumatology, Tohoku University Graduate School of Medicine
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Natural pregnancy and delivery after unrelated bone marrow transplantation using fludarabine-based regimen in a Fanconi anemia patient
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
- Secondary G-CSF Mobilized Blood Stem Cell Transplantation without Preconditioning in a Patient with Gaucher Disease : Report of a New Approach which Resulted in Complete Reversal of Severe Skeletal Involvement
- Fatal adenovirus infection indistinguishable from thrombotic microangiopathy after allogeneic CD34^+ peripheral progenitor cell transplantation
- Unmanipulated HLA-Haploidentical Bone Marrow Transplantation for the Treatment of Fatal, Nonmalignant Diseases in Children and Adolescents
- 小児期に骨髄移植を受けた患児の甲状腺機能の変化
- The Kinetics of Immune Reconstitution after Cord Blood Transplantation and Selected CD34^+ Stem Cell Transplantation in Children : Comparison with Bone Marrow Transplantation
- Final Height and Growth Hormone Secretion after Bone Marrow Transplantation in Children
- Linkage of expression of chemokine receptors (CXCR3 and CCR4) and cytotoxic molecules in peripheral T cell lymphoma, not otherwise specified and ALK-negative anaplastic large cell lymphoma
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas : Results of a Japanese Phase II Study
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Prediction of Sensitivity to STI571 among Chronic Myeloid Leukemia Patients by Genome-wide cDNA Microarray Analysis
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- No beneficial effect from addition of etoposide to daunorubicin,cytarabine,and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia:the JALSG-AML92 study
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult oatients with acute lymphoblastic leukemia: The ALL-87 Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma
- Primary Hepatic Follicular Lymphoma : A Case Report and Discussion of Chemotherapy and Favorable Outcomes
- Characterization of target genes at the 2p15-16 amplicon in diffuse large B-cell lymphoma
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Senile Epstein-Barr Virus-Associated B-Cell Lymphoproliferative Disorders : a Mini Review
- CD56/NCAM-Positive Langerhans Cell Sarcoma : A Clinicopathologic Study of 4 Cases
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Pilot Phase I/II Study of New Salvage Therapy(CHASE) for Refractory or Relapsed Malignant Lymphoma
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Two Cases of Acute Promyelocytic Leukemia Complicated by Torsade de Pointes during Arsenic Trioxide Therapy
- Two Patients with All-trans Retinoic Acid-Resistant Acute Promyelocytic Leukemia Treated Successfully with Gemtuzumab Ozogamicin as a Single Agent
- Delayed Recovery of Normal Hematopoiesis in Arsenic Trioxide Treatment of Acute Promyelocytic Leukemia: A Comparison to All-trans Retinoic Acid Treatment
- Prognostic Significance of CD7^+CD56^+ Phenotype and Chromosome 5 Abnormalities for Acute Myeloid Leukemia M0
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Current Status of Hematopoietic Cell Transplantation for Adult Patients with Hematologic Diseases and Solid Tumors in Japan
- Effective and Safe Interferon Treatment for Japanese Patients With Chronic Myelogenous Leukemia Relapse After Bone Marrow Transplantation
- Comparison of genetic aberrations in CD10^+ diffused large B-cell lymphoma and follicular lymphoma by comparative genomic hybridization and tissue-fluorescence in situ hybridization
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- CD34^+-Selected Autologous Peripheral Blood Stem Cell Transplantation Conditioned With Total Body Irradiation for Malignant Lymphoma: Increased Risk of Infectious Complications
- Assessment of Prognostic Factors in Follicular Lymphoma Patients
- Infrequent BCL10 Mutations in B-Cell Non-Hodgkin's Lymphomas
- Blast crisis of chronic myelogenous leukemia exhibiting immunophenotypic features of a myeloid/natural killer cell precursor
- A high dose chemoradiotherapy and peripheral blood stem cell support combined with the CD34^+-selection method in cyclin D1^+-mantle cell lymphoma
- Somatic Hypermutations in the V_H Segment of Immunoglobulin Genes of CD5-positive Diffuse Large B-Cell Lymphomas
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Multicenter Prospective Study of Interferon α versus Allogeneic Stem Cell Transplantation for Patients with New Diagnoses of Chronic Myelogenous Leukemia
- Serum concentrations of soluble HLA-class I and CD8 forms in patients with viral hepatic disorders
- Combination Chemotherapy With Risk Factor-Adjusted Dose Attenuation for High-Risk Myelodysplastic Syndrome and Resulting Leukemia in the Multicenter Study of the Japan Adult Leukemia Study Group (JALSG): Results of an Interim Analysis
- Re-Treatment of Relapsed Indolent B-Cell Lymphoma With Rituximab
- Hairy cell leukemia responsive to anti-thymocyte globulin used as immunosuppressive therapy for aplastic anemia
- Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
- A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Cord blood transplantation from sibling donors in Japan Report of the national survey
- I-cell Disease: Report of an Autopsy Case
- Thallium-201 Myocardial Imaging in Kawasaki Disease
- Quality of Life in Adult Patients After Stem Cell Transplantation
- Cytotoxic large T-cell lymphoma with fulminant clinical course,CD8^+ and CD56^-phenotype, and its relation to Epstein-Barr virus:a report of two cases
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- Serum thrombopoietin level after allogeneic bone marrow transplantation: possible correlations with platelet recovery, acute graft-versus-host disease and hepatic veno-occlusive disease
- Effect of a tyrosine kinase inhibitor STI571 in a patient with hepatic metastases from a duodenal gastrointestinal stromal tumor
- Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
- Epstein-Barr virus nuclear antigen 1-specific CD4^+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells
- Aberrant expression of BCL2A1-restricted minor histocompatibility antigens in melanoma cells : application for allogeneic transplantation
- Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions
- A pilot study of imatinib mesylate (STI571) on gastrointestinal stromal tumors in Japanese patients
- Intestinal Diffuse Large B-Cell Lymphoma Associated with Celiac Disease : A Japanese Case
- Primary cutaneous T-cell lymphoma of unspecified type with cytotoxic phenotype : Clinicopathological analysis of 27 patients
- Age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorders : Special references to lymphomas surrounding this newly recognized clinicopathologic disease
- Clinical Effects of Infusing Anti-Epstein -Barr Virus (EBV)-Specific Cytotoxic T-Lymphocytes into Patients with Severe Chronic Active EBV Infection
- Comparison of Soluble and Membrane Bound HLA-Class I and DR Levels in Umbilical Cord Blood and Adult Peripheral Blood
- The Generation of Immunocompetent Dendritic Cells From CD34^+ Acute Myeloid or Lymphoid Leukemia Cells
- The Impact of HLA-A Matching in Corneal Transplantation
- A simple and efficient purification of transduced cells by using green fluorescent protein gene as a selection marker
- Unification of Hematopoietic Stem Cell Transplantation Registries in Japan and Establishment of the TRUMP System
- Unrelated Donor Marrow Transplantation for Congenital Immunodeficiency and Metabolic Disease : An Update of the Experience of the Japan Marrow Donor Program
- Successful treatment of Aspergillus liver abscesses in a patient with acute monoblastic leukemia using combination antifungal therapy including micafungin as a key drug
- Micafungin-induced immune hemolysis attacks
- Long-term Efficacy of Pegylated Recombinant Human Megakaryocyte Growth and Development Factor in Therapy of Aplastic Anemia
- Two Cases Showing Clonal Progression With Full Evolution From Aplastic Anemia-Paroxysmal Nocturnal Hemoglobinuria Syndrome to Myelodysplastic Syndromes and Leukemia
- Progressive multifocal leukoencephalopathy after allogeneic bone marrow transplantation for Wiskott-Aldrich syndrome
- Bone Marrow Transplantation in Children
- Oral Melphalan, Dexamethasone, and Thalidomide for the Treatment of Refractory Multiple Myeloma
- Allogeneic Bone Marrow Transplantation in Children : Tokai Experience 1982 to 1984
- How High Can We Increase Complete Remission Rate in Adult Acute Myeloid Leukemia?
- 4 Activity of the Science Council of Japan Aiming for Tobacco-free Society in Japan(The 6th Anti-Smoking Promotion Seminar, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Age-related EBV-associated B-cell lymphoproliferative disorders : Diagnostic approach to a newly recognized clinicopathological entity
- Treatment of chronic myeloid leukemia with imatinib mesylate
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study